OBLIGATED GROUP FINANCIAL STATEMENT (UNAUDITED)

Similar documents
OBLIGATED GROUP FINANCIAL STATEMENT (UNAUDITED)

OBLIGATED GROUP FINANCIAL STATEMENT (UNAUDITED)

Sharp HealthCare Years Ended September 30, 2015 and 2014 With Report of Independent Auditors

Atchison Hospital Association, Inc. and Riverbend Regional Healthcare Foundation. Consolidated Financial Report September 30, 2015

Aurora Health Care, Inc. and Affiliates

Aurora Health Care, Inc. and Affiliates

Eisenhower Medical Center and Affiliates Years Ended June 30, 2015 and 2014 With Report of Independent Auditors

Mount Nittany Health System and Affiliates d/b/a Mount Nittany Health

Christiana Care Health Services, Inc. Financial Statements June 30, 2017 and 2016

Hunterdon Medical Center

RWJ BARNABAS HEALTH, INC. Consolidated Financial Statements. December 31, (With Independent Auditors Report Thereon)

South Shore Health System, Inc. and Subsidiaries

South Shore Health System, Inc. (Formerly South Shore Health and Educational Corporation) and Subsidiaries

A UDITED C OMBINED F INANCIAL S TATEMENTS

Beaumont Health and Consolidated Subsidiaries

Trinity Health Operating Income continues to climb in Q1 FY19

Hallmark Health Corporation and Affiliates

InterHealth Corp. and Affiliates dba PIH Health. Consolidated Financial Report September 30, 2016 and 2015

The Cooper Health System Years Ended December 31, 2015 and 2014 With Report of Independent Auditors

RWJ BARNABAS HEALTH, INC. Consolidated Financial Statements. December 31, 2017 and (With Independent Auditors Report Thereon)

THE SEEING EYE, INC. (A New Jersey Not-for-Profit Organization)

City Colleges of Chicago Foundation. Financial Statements as of and for the Years Ended June 30, 2010 and 2009, and Independent Auditors Report

SSM Health. Consolidated Financial Statements as of and for the Years Ended December 31, 2017 and 2016, and Independent Auditors Report

Trinity Health Operating Revenue Grows 5.5% to $9.5 billion in the First Half of FY19

Report of Independent Auditors and Financial Statements. 899 Charleston dba Moldaw Residences

TANNER MEDICAL CENTER, INC. REPORTS REQUIRED UNDER THE GAO S GOVERNMENT AUDITING STANDARDS AND THE SINGLE AUDIT ACT. for the year ended June 30, 2016

PHOEBE PUTNEY MEMORIAL HOSPITAL, INC. FINANCIAL STATEMENTS. for the years ended July 31, 2017 and 2016

DISCOVERY Children s Museum. Financial Report June 30, 2016

Mayo Clinic. Consolidated Financial Report December 31, 2012

OLE Health and Subsidiaries

CREIGHTON UNIVERSITY. Consolidated Financial Statements. June 30, 2017 and (With Independent Auditors Report Thereon)

THE SEEING EYE, INC. (A New Jersey Not-for-Profit Organization)

Aurora Health Care, Inc. and Affiliates

LAKELAND REGIONAL HEALTH SYSTEMS, INC. AND SUBSIDIARIES. Consolidated Financial Statements. September 30, 2017

CREIGHTON UNIVERSITY. Consolidated Financial Statements. June 30, 2018 and and. Schedule of Expenditures of Federal Awards.

SHEPPARD AND ENOCH PRATT FOUNDATION, INC. AND SUBSIDIARIES. June 30, 2011 and (With Independent Auditors Report Thereon)

Report of Independent Auditors and Financial Statements. Philanthropic Ventures Foundation

BON SECOURS HEALTH SYSTEM, INC. AND SUBSIDIARIES. Consolidated Financial Statements and Consolidating Schedules. August 31, 2009 and 2008

Jennie Stuart Medical Center, Inc.

SHEPPARD AND ENOCH PRATT FOUNDATION, INC. AND SUBSIDIARIES. June 30, 2016 and (With Independent Auditors Report Thereon)

NEBRASKA METHODIST HEALTH SYSTEM, INC. AND AFFILIATES. Consolidated Financial Statements. December 31, 2016 and 2015

City Colleges of Chicago Foundation. Financial Statements as of and for the Year Ended June 30, 2014, and Independent Auditors Report

CREIGHTON UNIVERSITY. Table of Contents. Page. Independent Auditors Report 1. Consolidated Financial Statements:

Project HOPE The People-to-People Health Foundation, Inc. Financial Report For the 18 Months Ended December 31, 2016

Children s Hospital of Pittsburgh Foundation

Christiana Care Health Services, Inc. Financial Statements June 30, 2014 and 2013

PHOEBE PUTNEY MEMORIAL HOSPITAL, INC. FINANCIAL STATEMENTS. for the years ended July 31, 2015 and 2014

The Associated: Jewish Community Federation of Baltimore, Inc. Associated Jewish Charities of Baltimore Jewish Community Investment Fund

Reports on the Audit of Federal Award Programs In Accordance with OMB Circular A-133

BRATTLEBORO MEMORIAL HOSPITAL FINANCIAL STATEMENTS. With Independent Auditors' Report

Scripps Health and Affiliates Years Ended September 30, 2014 and 2013 With Report of Independent Auditors

I N T E R I M U N A U D I T E D C O N S O L I D A T E D F I N A N C I A L S T A T E M E N T S A N D S U P P L E M E N T A R Y I N F O R M A T I O N

Christiana Care Health Services, Inc. Financial Statements June 30, 2013 and 2012

CAMC Health System, Inc. and Subsidiaries

Xavier University. Financial Statements as of and for the Years Ended June 30, 2016 and 2015, and Independent Auditors Report

JUPITER MEDICAL CENTER, INC. AND AFFILIATED COMPANIES. Jupiter, Florida. CONSOLIDATED FINANCIAL STATEMENTS September 30, 2015 and 2014

Oklahoma State University Foundation. Financial Report June 30, 2016

CREIGHTON UNIVERSITY. Consolidated Financial Statements. June 30, 2016 and and. Schedule of Expenditures of Federal Awards.

I N T E R I M U N A U D I T E D C O N S O L I D A T E D F I N A N C I A L S T A T E M E N T S A N D S U P P L E M E N T A R Y I N F O R M A T I O N

The Rehabilitation Institute of Kansas City and The Rehabilitation Institute Industries, Inc.

Young Men s Christian Association of Greater Richmond

Sanford Burnham Prebys Medical Discovery Institute

FLOYD HEALTHCARE MANAGEMENT, INC. ROME, GEORGIA COMBINED FINANCIAL STATEMENTS. for the years ended June 30, 2012 and 2011

Laurel Lake Retirement Community, Inc. and Subsidiary YEARS ENDED DECEMBER 31, 2018 AND 2017

PHOEBE PUTNEY MEMORIAL HOSPITAL, INC. FINANCIAL STATEMENTS. for the years ended July 31, 2016 and 2015

PORTER MEDICAL CENTER, INC. AND SUBSIDIARIES

SSM Health. Consolidated Financial Statements as of and for the Years Ended December 31, 2016 and 2015, and Independent Auditors Report

Concord Hospital, Inc. and Subsidiaries

Financial Statements Years Ended June 30, 2013 and Children's Hospital and Healthcare Services Foundation

SEATTLE CHILDREN S HEALTHCARE SYSTEM. Consolidated Financial Statements. September 30, 2014 and (With Independent Auditors Report Thereon)

Mayo Clinic. Consolidated Financial Report December 31, 2013

Melwood Horticultural Training Center, Inc. and Affiliates. Consolidated Financial Report June 30, 2018

Cedars-Sinai Medical Center Years Ended June 30, 2016 and 2015 With Report of Independent Auditors

HELEN PORTER NURSING HOME, INC.

Berry College, Inc. Consolidated Financial Statements and Reports and Schedules Related to the Uniform Guidance Years Ended June 30, 2016 and 2015

GUSTAVUS ADOLPHUS COLLEGE Saint Peter, Minnesota

GEORGIA HEALTH SCIENCES FOUNDATION, INC.

JUPITER MEDICAL CENTER, INC. AND AFFILIATED COMPANIES. Jupiter, Florida. CONSOLIDATED FINANCIAL STATEMENTS September 30, 2014 and 2013

SCHOLARSHIP AMERICA, INC.

Annenberg Center for Health Sciences at Eisenhower Years Ended June 30, 2014 and 2013 With Report of Independent Auditors

Mount Sinai Medical Center of Florida, Inc. and Subsidiaries

SEATTLE CHILDREN S HOSPITAL. EIN No OMB Circular A-133. Supplementary Financial Report. Year ended September 30, 2013

Cedars-Sinai Medical Center Year Ended June 30, 2016 With Report of Independent Auditors

Englewood Hospital and Medical Center and Subsidiaries

NORTH MISSISSIPPI MEDICAL CENTER, INC., CLAY COUNTY MEDICAL CORPORATION, AND WEBSTER HEALTH SERVICES, INC. (The Obligated Group)

CONSOLIDATED FINANCIAL STATEMENTS AND OTHER FINANCIAL INFORMATION. OhioHealth Corporation. Years Ended June 30, 2018 and 2017

San Antonio Regional Hospital and Subsidiaries Years Ended December 31, 2015 and 2014 With Report of Independent Auditors

Chaminade University of Honolulu

St. Anthony s Medical Center and Affiliates

Drake University. Financial Statements as of and for the Years Ended June 30, 2016 and 2015, and Independent Auditors Report

McLaren Health Care Corporation and Subsidiaries. Consolidated Financial Report with Additional Information September 30, 2017

METHODIST LE BONHEUR HEALTHCARE AND AFFILIATES. Combined Financial Statements. December 31, 2016 and (With Independent Auditors Report Thereon)

Tallahassee Memorial HealthCare, Inc. September 19, 2013

THE SEEING EYE, INC. (A New Jersey Not-for-Profit Organization)

UNIVERSITY HOSPITALS HEALTH SYSTEM, INC. Consolidated Financial Statements. December 31, 2016 and (With Independent Auditors Reports Thereon)

The Rehabilitation Institute of Kansas City and The Rehabilitation Institute Industries, Inc.

Children s Hospital of Wisconsin, Inc. and Children s Hospital and Health System Foundation, Inc.

Audited Financial Statements

Report of Independent Auditors and Consolidated Financial Statements. Sacramento Region Community Foundation

United Way for Southeastern Michigan. Consolidated Financial Report June 30, 2017

Transcription:

OBLIGATED GROUP FINANCIAL STATEMENT (UNAUDITED) 3 rd QUARTER JUNE 2018

Obligated Group Financial Statements and Other Financial Information (Unaudited) For the Quarter and Nine Months Ended June 30, 2018 Contents Obligated Group Financial Statements (Unaudited) Obligated Group Balance Sheet...1 Obligated Group Statement of Operations...2 Obligated Group Statement of Changes in Net Assets...3 Obligated Group Statement of Cash Flows...4 Notes to Obligated Group Financial Statements...5 Other Financial Information Management s Discussion and Analysis...26 Analysis of Obligated Group Financial Statements...34

SHARP HEALTHCARE OBLIGATED GROUP BALANCE SHEET (UNAUDITED) June 30, 2018 ($ in 000's) ASSETS LIABILITIES AND NET ASSETS JUNE JUNE SEPTEMBER JUNE JUNE SEPTEMBER 2018 2017 2017 2018 2017 2017 Current assets: Current liabilities: Cash and cash equivalents $ 328,958 $ 229,300 $ 225,176 Accounts payable and accrued liabilities $ 356,009 $ 215,123 $ 240,003 Short-term investments 44,840 127,479 48,908 Intercompany payables, net 34,942 1,939 147 Accounts receivable, net 379,711 320,524 312,407 Accrued compensation and benefits 156,789 136,528 140,225 Intercompany receivables, net 2,362 1,880 2,651 Current portion of long-term debt 18,181 17,982 18,021 Inventories 46,171 45,851 45,786 Estimated settlements payable Prepaid expenses and other 107,707 63,191 89,818 to government programs, net 1,236 1,841 2,516 Total current assets 909,749 788,225 724,746 Accrued interest 9,283 8,899 3,731 Total current liabilities 576,440 382,312 404,643 Long-term investments 215,979 203,148 196,518 Long-term liabilities 127,998 161,635 127,189 Reserves for professional liability 2,700 3,900 4,700 Long-term debt 772,479 632,329 618,335 Assets limited as to use: Total liabilities 1,479,617 1,180,176 1,154,867 Designated for property 2,168,908 1,920,995 2,002,395 Under bond indentures 133,605 50,987 49,770 Total assets limited as to use 2,302,513 1,971,982 2,052,165 Net Assets: Unrestricted 3,443,649 3,107,138 3,202,551 Temporarily restricted 67,631 59,324 60,908 Permanently restricted 8,992 6,694 6,698 Net property, plant and equipment 1,418,468 1,235,737 1,299,652 Other assets 56,030 67,760 65,910 Ending net assets 3,520,272 3,173,156 3,270,157 Beneficial interest in foundations 97,150 86,480 86,033 Total Liabilities and Total Assets $ 4,999,889 $ 4,353,332 $ 4,425,024 Net Assets $ 4,999,889 $ 4,353,332 $ 4,425,024

OBLIGATED GROUP STATEMENT OF OPERATIONS (UNAUDITED) FOR THE QUARTER ENDED JUNE 30, 2018 AND NINE MONTHS ENDED JUNE 30, 2018 ($ in 000's) QUARTER YEAR - TO - DATE Last Year Actual Budget Variance D E S C R I P T I O N Last Year Actual Budget Variance $ 482,292 $ 512,438 $ 480,623 $ 31,815 NET PATIENT SERVICE REVENUE $ 1,411,840 $ 1,503,151 $ 1,431,783 $ 71,368-33,003 30,749 2,254 PROVIDER TAX REVENUE 86,364 196,974 244,755 (47,781) 253,095 253,793 260,663 (6,870) PREMIUM REVENUE 751,890 761,444 773,262 (11,818) 25,595 29,056 27,977 1,079 OTHER OPERATING REVENUE 72,176 82,900 83,474 (574) 760,982 828,290 800,012 28,278 TOTAL OPERATING REVENUE 2,322,270 2,544,469 2,533,274 11,195 OPERATING EXPENSES: 383,362 402,548 398,408 (4,140) Staffing 1,141,168 1,204,407 1,187,517 (16,890) 100,783 112,316 101,959 (10,357) Supplies 297,549 317,627 303,655 (13,972) 74,481 80,472 80,249 (223) Medical fees 237,856 244,624 248,478 3,854 82,404 89,323 83,927 (5,396) Purchased services 244,900 251,676 244,939 (6,737) - 22,790 23,241 451 Provider tax 55,006 133,298 175,344 42,046 30,987 31,397 32,294 897 Maint., utilities & rentals 90,995 92,325 95,610 3,285 3,521 6,173 3,373 (2,800) Business insurance 11,253 12,781 10,074 (2,707) 7,800 7,928 7,132 (796) Other 23,786 22,250 22,307 57 683,338 752,947 730,583 (22,364) TOTAL OPERATING EXPENSES 2,102,513 2,278,988 2,287,924 8,936 77,644 75,343 69,429 5,914 EBITDA from Operations 219,757 265,481 245,350 20,131 27,569 28,915 29,427 512 Depreciation & amortization 80,994 84,099 85,568 1,469 28 63 21 (42) Taxes 82 110 62 (48) 6,143 5,141 6,348 1,207 Interest 18,315 15,876 18,159 2,283 43,904 41,224 33,633 7,591 INCOME FROM OPERATIONS 120,366 165,396 141,561 23,835 5.8% 5.0% 4.2% - % OF OPERATING REVENUE 5.2% 6.5% 5.6% - NON-OPERATING INCOME 51,794 9,930 24,456 (14,526) Investment income 117,208 62,568 68,534 (5,966) (18) 1,519-1,519 Mark to market swaps 7,696 3,823-3,823 (1,075) 6,801 6,838 (37) Other income (loss) (3,507) (6,518) 4,340 (10,858) 50,701 18,250 31,294 (13,044) TOTAL NON-OPERATING INCOME 121,397 59,873 72,874 (13,001) 94,605 59,474 64,927 (5,453) EXCESS OF REVENUE OVER EXPENSES 241,763 225,269 214,435 10,834 12.4% 7.2% 8.1% - % OF OPERATING REVENUE 10.4% 8.9% 8.5% - $ 128,345 $ 93,593 $ 100,723 $ (7,130) EBITDA $ 341,154 $ 325,354 $ 318,224 $ 7,130

SHARP HEALTHCARE OBLIGATED GROUP STATEMENT OF CHANGES IN NET ASSETS (UNAUDITED) FOR THE QUARTER ENDED JUNE 30, 2018 AND NINE MONTHS ENDED JUNE 30, 2018 ($ in 000's) Quarter YTD Prior YTD Unrestricted net assets: Excess of revenues over expenses $ 59,474 $ 225,269 $ 241,763 Net assets released from restrictions used for the purchase of property, plant and equipment 4,704 13,104 12,252 Beneficial Interest in Foundations 988 2,725 2,738 Increase in unrestricted net assets 65,166 241,098 256,753 Temporarily restricted net assets: Beneficial Interest in Foundations 1,617 6,723 4,018 Increase in temporarily restricted net assets 1,617 6,723 4,018 Permanently restricted net assets: Beneficial Interest in Foundations 94 2,294 41 Increase in permanently restricted net assets 94 2,294 41 Increase in net assets 66,877 250,115 260,812 Net assets, beginning 3,453,395 3,270,157 2,912,344 Net assets, ending $ 3,520,272 $ 3,520,272 $ 3,173,156 3

SHARP HEALTHCARE OBLIGATED GROUP STATEMENT OF CASH FLOWS (UNAUDITED) FOR THE QUARTER ENDED JUNE 30, 2018 AND NINE MONTHS ENDED JUNE 30, 2018 ($ in 000's) Quarter YTD Prior YTD CASH FLOWS FROM OPERATING ACTIVITIES AND OTHER INCOME: Increase in net assets $ 66,877 $ 250,115 $ 260,812 Adjustments to reconcile increase in net assets to net cash provided by operating activities: Net assets transferred from related party (3,087) (9,733) (8,499) Depreciation of operating and nonoperating facilities 28,915 84,099 80,994 Amortization, including deferred financing costs (168) (376) (68) Other operating losses, net - - 2,150 Other non-operating (gains) losses, net (8,059) 2,295 (141) Change in net unrealized (gains) losses on investments 6,064 (16,177) 98,482 Change in net unrealized (gains) losses on swap activity (1,519) (3,823) (7,696) Changes in operating assets and liabilities: (Increase) decrease in: Short-term investments 1,777 4,068 (88,249) Accounts receivable, net 71,519 (67,304) 18,242 Intercompany receivable 32,150 35,084 3,312 Inventories (398) (385) 531 Prepaid expenses (9,968) (17,889) (9,127) Long-term investments (2,226) (19,461) 35,410 Assets Limited as to use (29,503) (234,171) (289,382) Other assets 2,763 (7,487) - (Decrease) increase in: Accounts payable and accrued liabilities 37,324 116,006 (10,929) Accrued compensation and benefits 12,896 16,564 3,354 Est. settlements payable to govt programs, net 3,356 (1,280) 4,396 Accrued interest 4,886 5,552 5,124 Other long-term liabilities (8,650) 809 10,655 Reserve for malpractice (2,000) (2,000) - Cash provided by operating activites 202,949 134,506 109,371 CASH FLOWS FROM INVESTING ACTIVITIES: Acquisition of property, plant and equipment, net of retirements (113,027) (193,472) (99,651) Change in other assets 10,072 10,072 (11,947) Investments in joint ventures - - (670) Distributions from joint ventures - - 1,664 Cash used in investing activities (102,955) (183,400) (110,604) CASH FLOWS FROM FINANCING ACTIVITIES: Current maturities and payments on long-term debt (235) (706) (701) Current payments under capital lease obligations (1,120) (3,265) (3,088) Extinguishment of long-term debt (29,888) (147,750) - Proceeds from the issuance of long-term debt, net - 304,397 - Transfers, other changes in long-term debt - - (38,256) Cash provided by (used in) financing activities (31,243) 152,676 (42,045) NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 68,751 103,782 (43,278) BEGINNING CASH AND CASH EQUIVALENTS BALANCE 260,207 225,176 272,578 ENDING CASH AND CASH EQUIVALENTS BALANCE $ 328,958 $ 328,958 $ 229,300 SUPPLEMENTAL DISCLOSURE OF NON CASH INVESTING AND FINANCING ACTIVITIES: Capital lease obligations for building and equipment $ - $ (544) $ 950 Net assets transferred from a related party $ 3,087 $ 9,733 $ 8,499 4

Notes to Obligated Group Financial Statements (Unaudited) Quarter Ended June 30, 2018 1. Summary of Significant Accounting Policies Organization Sharp HealthCare (SHC) is a California nonprofit public benefit corporation with corporate offices in San Diego, California. SHC, together with its affiliated entities (collectively Sharp), constitute a regional integrated health care delivery system which does business as Sharp HealthCare, primarily serving the residents of San Diego County and includes the following: Sharp Memorial Hospital (SMH), including Stephen Birch Healthcare Center, Sharp Mary Birch Hospital for Women & Newborns (SMBHWN), Sharp Outpatient Pavilion, Sharp Mesa Vista Hospital, and Sharp McDonald Center (formerly Sharp Vista Pacifica) Sharp Chula Vista Medical Center (SCVMC) Sharp Grossmont Hospital (SGH) Sharp Coronado Hospital and HealthCare Center (SCHHC) Sharp Health Plan (SHP) Continuous Quality Insurance SPC (CQI SPC) Sharp HealthCare Foundation (SHF) Grossmont Hospital Foundation (GHF) SHC, SMH, SCVMC and SGH are collectively the Obligated Group under certain bond indentures. The obligated group records beneficial interest in SHF and GHF, which are not members of the obligated group. SHC has certain contractual obligations with its affiliates that govern its operations and the use of certain assets. All significant transactions among Sharp s obligated group entities have been eliminated in the accompanying obligated group financial statements. Use of Estimates The preparation of Sharp s obligated group financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the obligated group financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. 5

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Cash and Cash Equivalents Cash and cash equivalents include investments in highly liquid debt instruments with original maturities of three months or less. Sharp routinely invests its surplus operating funds in money market mutual funds. These funds generally invest in highly liquid U.S. government and agency obligations. Inventories Inventories, consisting principally of supplies, are stated at the lower of cost or market value. Short-Term Investments Short-term investments are classified as trading and include corporate and government obligation securities, which are included in professionally managed portfolios, and are measured at fair value in the balance sheet. The maturities of these securities do not exceed one year. Investment income or loss (including unrealized and realized gains and losses) is included in the obligated group Excess of Revenue over Expenses. Long-Term Investments Long-term investments are classified as trading, which are included in professionally managed portfolios, and are measured at fair value in the balance sheet. The maturities of these securities are in excess of one year or are investments in equities which are not expected to be liquidated over the next year. Investment income or loss (including unrealized and realized gains and losses) is included in the obligated group Excess of Revenue over Expenses. Assets Limited as to Use Assets limited as to use invested in debt and equity securities with readily determined fair values are measured at fair value in the balance sheet and are classified as trading. Investment income or loss (including unrealized and realized gains and losses) is included in the obligated group Excess of Revenue over Expenses unless the income or loss is restricted by donor or law. 6

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Assets Limited as to Use (continued) Assets limited as to use primarily include assets set aside by Sharp s Board of Directors (the Board) for future capital improvements, over which the Board retains control and may at its discretion subsequently use for other purposes, and amounts held by trustees under indenture agreements. Assets limited as to use consist of the following: Designated for property Cash resources not required for operations have been designated as funded depreciation to be used for future capital improvements. This designation may be changed and such funds used for other purposes $26.0 million at June 30, 2018, and $26.5 million at June 30, 2017, of such assets are pledged as collateral for notes payable and other liabilities. Under bond indentures In accordance with the terms of Sharp s various bond indentures, certain bond proceeds and principal and interest payments have been deposited with a trustee and are limited as to use in accordance with the related indentures. Derivative and Hedging Instruments Sharp recognizes all derivatives on its obligated group balance sheets at fair value. Derivatives that are not effective hedges are adjusted to fair value through the obligated group statements of operations. At June 30, 2018 and 2017, the outstanding hedging instruments were not considered effective hedges. Property and Equipment Property and equipment acquisitions are recorded at cost. Depreciation is provided over the estimated useful life of each class of depreciable asset from 3 to 40 years and is computed using the straight-line method. Property and equipment under capital lease obligations is amortized on the straight-line method over the shorter of the lease term or the estimated useful life of the asset. Such amortization is included in depreciation and amortization in the obligated group financial statements. Interest cost incurred on borrowed funds during the period of construction of qualifying capital assets is capitalized as a component of the cost of acquiring those assets. Gifts of long-lived assets such as land, buildings, or equipment are reported as unrestricted support unless explicit donor stipulations specify how the donated assets must be used. Gifts of long-lived assets with explicit restrictions that specify how the assets are to be used and gifts of cash or other assets that must be used to acquire long-lived assets are reported as restricted support. Absent explicit donor stipulations about how long those long-lived assets must be maintained, expirations of donor restrictions are reported when the donated or acquired longlived assets are placed in service. 7

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Unamortized Financing Costs Costs incurred in obtaining long-term financing are amortized over the terms of the related obligations using the effective interest method and are presented as a reduction to the carrying value of long term debt. Temporarily and Permanently Restricted Net Assets Temporarily restricted net assets are those whose use by Sharp has been limited by donors to a specific time period or purpose. Permanently restricted net assets have been restricted by donors to be maintained by Sharp in perpetuity. Impairment or Disposal of Long-Lived Assets Sharp accounts for the impairment or disposal of long-lived assets using a future cash flow model to determine whether assets have been impaired. Sharp regularly reviews long-lived assets for circumstances which could indicate carrying values may not be recoverable. No impairments were recorded in fiscal years 2018 or 2017. Income from Operations Sharp s primary purpose is to provide diversified health care services to the community served by its affiliates. Only those activities directly associated with the furtherance of this purpose are considered operating activities and classified as operating revenues and expenses. Items excluded from Income from Operations consist of investment income, gains and losses on disposition of property and equipment, changes in the fair value of interest rate swaps, and fundraising expense. Excess of Revenue over Expenses The accompanying obligated group statements of operations and changes in net assets include Excess of Revenue over Expenses and other changes in unrestricted net assets. Changes in unrestricted net assets which are excluded from Excess of Revenue over Expenses, consistent with industry practice, include permanent transfers of assets to and from affiliates for other than goods and services, long-lived assets acquired using contributions which by donor restriction were to be used for the purposes of acquiring such assets, pension-related changes other than net periodic pension cost, and beneficial interest in the foundations. 8

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Net Patient Service Revenues Sharp has agreements with third-party payors that provide for payments to Sharp at amounts different from its established rates. Payment arrangements include prospectively determined rates per discharge, reimbursed costs, discounted charges and per diem payments. Net patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors, and others for services rendered, including estimated retroactive adjustments under reimbursement agreements with third-party payors. Retroactive adjustments are accrued on an estimated basis in the period the related services are rendered and adjusted in future periods, as final settlements are determined. In the opinion of management, adequate provision has been made for such adjustments. Accounts receivable are reduced by an allowance for doubtful accounts. In evaluating the collectability of accounts receivable, Sharp analyzes its past history and identifies trends for each of its major payor sources of revenue to estimate the appropriate allowance for doubtful accounts. Management regularly reviews data about these major payor sources of revenue in evaluating the sufficiency of the allowance for doubtful accounts. For receivables associated with services provided to patients who have third-party coverage, Sharp analyzes contractually due amounts and provides an allowance for doubtful accounts, if necessary. For receivables associated with self-pay patients (which includes both patients without insurance and patients with deductible and copayment balances due for which third-party coverage exists for part of the bill), Sharp records a provision for doubtful accounts in the period of service on the basis of its past experience, which indicates that many patients are unable or unwilling to pay the portion of their bill for which they are financially responsible. The difference between the standard rates (or the discounted rates if negotiated) and the amounts actually collected after all reasonable collection efforts have been exhausted is charged to the allowance for doubtful accounts. Sharp s obligated group allowance for doubtful accounts for self-pay patients was 87.1% and 85.7% of self-pay accounts receivable at June 30, 2018 and 2017, respectively. In addition, Sharp s obligated group self-pay write-offs increased $3.1 million from $19.9 million for the nine months ended June 30, 2017 to $23.0 million for the nine months ended June 30, 2018. Sharp did not change its charity care or uninsured discount policies during the quarter ended June 30, 2018. Sharp does not maintain a material allowance for doubtful accounts from thirdparty payors, nor did it have significant write-offs from third-party payors. 9

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Net Patient Service Revenues (continued) The mix of obligated group hospital net patient service revenues, net of contractual allowances, discounts and provision for doubtful accounts was as follows: Nine Months Ended June 30, 2018 2017 Government 46% 45% Contracted 53 54 Self-pay and Other 1 1 Premium Revenues Sharp has agreements with various employers and health maintenance organizations to provide medical services to subscribing participants. Under these agreements, Sharp receives monthly capitation payments based on the number of participants who have selected Sharp, regardless of services actually performed by Sharp. Other Revenues Other revenues include unrestricted donations, retail pharmacy gross profits, management services and joint venture income. Health Care Service Costs Sharp contracts with certain health care providers for the provision of medical services to eligible members. These services include primary care and specialty physician services, inpatient and outpatient facility services, pharmacy, and other medical services. Providers are paid on capitated, per diem, and structured fee-for-service bases. Health care service costs (included in medical fees and purchased services in the accompanying obligated group statements of operations) are accrued in the period in which the services are provided to enrollees, based in part on estimates, including estimates of medical services provided but not yet reported to Sharp. 10

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Charity Care Sharp s policy is to accept all patients regardless of their ability to pay. In assessing a patient s ability to pay, Sharp utilizes financial eligibility requirements or criteria. Sharp provides care to patients who meet certain criteria under its charity care policy without charge or at amounts less than its established rates. Because Sharp does not pursue collection of amounts determined to qualify as charity care, such amounts are not reported as revenue. Charity care costs are calculated using a ratio of cost to gross charge methodology by department. The calculation includes direct revenues and costs of each department, in addition to a step down of overhead costs. Donor-Restricted Gifts Unconditional promises to give cash and other assets to Sharp are reported at fair value at the date the promise is received. Conditional promises to give and indications or intentions to give are reported at fair value at the date the gift becomes unconditional. The gifts are reported as either temporarily or permanently restricted support if they are received with donor stipulations that limit the use of the donated assets. When a donor restriction expires, that is, when a stipulated time restriction ends or purpose restriction is accomplished, temporarily restricted net assets are reclassified as unrestricted net assets and reported in the obligated group statements of operations as other operating revenues. Donor-restricted contributions whose restrictions are met within the same year as received are reported as unrestricted contributions in the obligated group financial statements. Income Taxes The principal operations of Sharp are exempt from taxation pursuant to Section 501(c)(3) of the Internal Revenue Code and related California provisions. Sharp recognizes tax benefits from any uncertain tax positions only if it is more likely than not the tax position will be sustained, based solely on its technical merits, with the taxing authority having full knowledge of all relevant information. Sharp records a liability for unrecognized tax benefits from uncertain tax positions as discrete tax adjustments in the first interim period that the more likely than not threshold is not met. Sharp recognizes deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of its assets and liabilities along with net operating loss and tax credit carryovers only for tax positions that meet the more likely than not recognition criteria. At June 30, 2018 and 2017, no such assets or liabilities were recorded. 11

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Adoption of New Accounting Pronouncements In September 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity s Ability to Continue as a Going Concern, which requires an entity s management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). Sharp adopted ASU 2014-15 on October 1, 2016, which did not have an impact on Sharp s obligated group financial statements. In April 2015, the FASB issued ASU 2015-03, Interest Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs, which simplifies the presentation of debt issuance costs by requiring that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying amount of debt liability, consistent with debt discounts or premiums. Sharp adopted ASU 2015-03 on October 1, 2016, with full retrospective application, which had the impact of reducing the amount of previously reported long-term debt by the amount of debt issuance costs included in the accompanying obligated group balance sheets. In May 2015, the FASB issued ASU 2015-07, Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent), which permits a reporting entity, as a practical expedient, to measure the fair value of certain investments using the net asset value of such investments. Sharp adopted ASU 2015-07 on October 1, 2016, which did not have an impact on Sharp s obligated group financial statements. In December 2016, the FASB issued ASU 2016-19, Technical Corrections and Improvements, which amends various subsections of the FASB Accounting Standards Codification. While the majority of the amendments to the Codification are minor, FASB ASC 350-40 was amended to clarify that internal-use software licensed from a third party should be accounted for as the acquisition of an intangible asset and the incurrence of a liability (i.e., to the extent that all or a portion of the software licensing fees are not paid on or before the acquisition date of the license) by the licensee. Sharp adopted ASU 2016-19 on October 1, 2017, which did not have a material impact on Sharp s obligated group financial statements. 12

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Recent Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which deferred the effective date of ASU 2014-09 by one year. As a result, the adoption of ASU 2014-09 is required for Sharp on October 1, 2018. In March 2016, April 2016, and May 2016, the FASB issued ASU 2016-08, ASU 2016-10, and ASU 2016-12, respectively. These amendments to ASC 606 did not change the core principle of the guidance but rather clarified the implementation guidance for certain considerations. Management is currently evaluating the effect of this guidance on Sharp s obligated group financial statements. In January 2016, the FASB issued ASU 2016-01, Financial Instruments Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, which provides revised guidance concerning certain matters involving the recognition, measurement, and disclosure of financial assets and financial liabilities. Among other things, ASU 2016-01 requires equity investments, except those accounted for under the equity method of accounting or those that result in consolidation, to be measured at fair value with changes in fair value recognized in net income, simplifies the impairment assessment of equity investments not having readily determinable fair values by requiring a qualitative assessment to identify impairment so that it is similar to the qualitative assessment applied to long-lived assets, goodwill, and indefinite-lived intangibles, and eliminates the requirement to disclose the fair value of financial instruments measured at amortized cost for non-public entities. The revised guidance does not alter the basic framework for classifying debt instruments held as financial assets. The adoption of ASU 2016-01 is required for Sharp on October 1, 2018. In February 2018 the FASB issued ASU 2018-03; this amendment to ASC 825-10 did not change the core principle of the guidance but rather clarified the implementation guidance for certain considerations. Management is currently evaluating the effect of this guidance, if any, on Sharp s obligated group financial statements. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which establishes a new lease accounting model for lessees. Under the new guidance, lessees will be required to recognize so-called right-of-use assets and liabilities for most leases having lease terms of 12 months or more. However, lease expense will be recognized on the income statement in a manner similar to existing requirements. The adoption of ASU 2016-02 is required for Sharp on October 1, 2019, and management is currently evaluating the effect of this guidance on Sharp s obligated group financial statements. 13

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Recent Accounting Pronouncements (continued) In August 2016, the FASB issued ASU 2016-14, Not-for-Profit Entities (Topic 958): Presentation of Financial Statements of Not-for-Profit Entities. Under the new guidance, the current three classes of net assets (i.e., unrestricted, temporarily restricted, and permanently restricted) have been replaced with two new classes of net assets: net assets with donor restrictions; and net assets without donor restrictions. The main provisions of this update are to present on the face of the statement of financial position and on the face of the statement of activities amounts for two classes of net assets at the end of the period, rather than for the currently required three classes, and continue to present on the face of the statement of cash flows the net amount for operating cash flows using either the direct or indirect method of reporting but no longer require the presentation or disclosure of the indirect method (reconciliation) if using the direct method. This update also requires the enhanced disclosures about self-imposed limits on the use of resources, composition of net assets with donor restrictions, disclosures about liquidity and availability of resources, amounts of expenses by both their natural classification and their functional classification, methods used to allocate costs among program and support functions, and other disclosures to improve the usefulness of information provided to donors, grantors, creditors, and other users of financial statements. The adoption of ASU 2016-14 is required for Sharp on October 1, 2018, and management is currently evaluating the effect of this guidance on Sharp s obligated group financial statements. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, a consensus of the FASB Emerging Issues Task Force (EITF). This ASU, which addresses eight specific classification issues, is intended to reduce diversity in current practice regarding the manner in which certain cash receipts and cash payments are presented and classified in the cash flow statement, as GAAP did not include guidance on the cash flow statement classification of the issues covered prior to the guidance in ASU 2016-15. The adoption of ASU 2016-15 is required for Sharp on October 1, 2018, and management is currently evaluating the effect of this guidance, if any, on Sharp s obligated group financial statements. 14

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Recent Accounting Pronouncements (continued) In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash, a consensus of the FASB Emerging Issues Task Force (EITF). The amendments in this update require that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginningof-period and end-of-period total amounts shown on the statement of cash flows. The amendments in this ASU do not provide a definition of restricted cash or restricted cash equivalents. The adoption of ASU 2016-18 is required for Sharp on October 1, 2018, and management is currently evaluating the effect of this guidance, if any, on Sharp s obligated group financial statements. In January 2017, the FASB issued ASU 2017-02, Clarifying When a Not-for-Profit That is a General Partner or a Limited Partner Should Consolidate a For-Profit Partnership or Similar Entity, which provides clarifying guidance on when a not-for-profit general partner should consolidate a for-profit limited partnership. The clarifying guidance maintains current U.S. GAAP under which a general partner is presumed to control a for-profit limited partnership, regardless of the level of ownership interest, unless the presumption of control is overcome. The adoption of ASU 2017-02 is required for Sharp on October 1, 2018, and management is currently evaluating the effect of this guidance, if any, on Sharp s obligated group financial statements. In March 2017, the FASB issued ASU 2017-06, Plan Accounting Defined Benefit Pension Plans (Topic 960), Defined Contribution Pension Plans (Topic 962), Health and Welfare Benefit Plans (Topic 965): Employee Benefit Plan Master Trust Reporting, a consensus of the FASB Emerging Issues Task Force (EITF), which enhances the disclosure and financial statement presentation requirements for an employee benefit plan s interest in a master trust and aligns such requirements across all employee benefit plans. The adoption of ASU 2017-06 is required for Sharp on October 1, 2019, and management is currently evaluating the effect of this guidance, if any, on Sharp s obligated group financial statements. 15

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Recent Accounting Pronouncements (continued) In March 2017, the FASB issued ASU 2017-07, Compensation Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which amends the FASB Accounting Standards Codification to improve the presentation of net periodic pension cost and net periodic postretirement benefit cost in the financial statements. In particular, ASU 2017-07 requires the service cost component to be included in the same line item as other compensation costs arising from services rendered by relevant employees during the period, with the other (i.e., non-service cost) components of net benefit cost presented in the income statement separately from the service cost component. The adoption of ASU 2017-07 is required for Sharp on October 1, 2018, and management is currently evaluating the effect of this guidance, if any, on Sharp s obligated group financial statements. In April 2017, the FASB issued ASU 2017-08, Receivables Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities, which requires that the premium on an individual callable debt security having an explicit, noncontingent call feature that is callable at fixed prices on preset dates be amortized to the earliest call date. After the earliest call date, if the call option is not exercised, then the yield should be reset using the payment terms required by the debt security. The adoption of ASU 2017-08 is required for Sharp on October 1, 2019, and management is currently evaluating the effect of this guidance, if any, on Sharp s obligated group financial statements. In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which changed both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedging results. The adoption of ASU 2017-12 is required for Sharp on October 1, 2019, and management is currently evaluating the effect of this guidance, if any, on Sharp s obligated group financial statements. In January 2018, the FASB issued ASU 2018-01, Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842, which establishes a practical expedient for transition to Topic 842 for land easements concurrent with the adoption of FASB ASU 2016-02. Under the new guidance entities have the option, with land easements to which they do not apply current leases guidance and which exist or will expire before the adoption of FASB ASU 2016-02, to not evaluate such land easements under Topic 842. The adoption of ASU 2018-01 is required for Sharp when FASB ASU 2016-02 becomes effective, on October 1, 2019, and management is currently evaluating the effect of this guidance, if any, on Sharp s obligated group financial statements. 16

Notes to Obligated Group Financial Statements (Unaudited) (continued) 1. Summary of Significant Accounting Policies (continued) Recent Accounting Pronouncements (continued) In June 2018, the FASB issued ASU 2018-08, Not-for-Profit Entities (Topic 958): Clarifying the Scope and the Accounting Guidance for Contributions Received and Contributions Made, which assists not-for-profit and other entities in (1) evaluating whether transactions should be accounted for as contributions (i.e., non-reciprocal transactions) within the scope of the FASB ASC Topic 958, Not-for-Profit Entities, or as exchange (i.e., reciprocal) transactions subject to other guidance (e.g., FASB ASC 606, Revenue from Contracts with Customers), and (2) distinguishing between conditional and unconditional contributions. The adoption of ASU 2018-08 is required for Sharp on October 1, 2019 for transactions in which Sharp serves as a resource recipient and on October 1, 2020 for transactions in which Sharp serves as a resource provider. Management is currently evaluating the effect of this guidance, if any, on Sharp s obligated group financial statements. 2. Fair Value Measurements FASB ASC 820 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, FASB ASC 820 establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Pricing is based on observable inputs such as quoted prices in active markets. Financial assets and liabilities in Level 1 include U.S. Treasury securities and listed equities. Level 2: Pricing inputs are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Financial assets and liabilities in this category generally include corporate bonds, U.S. government agency securities, commercial paper, supranational bonds, negotiable certificates of deposit, fixed income funds, mortgage-backed securities, interest rate swaps, and commingled plan trust funds. 17

Notes to Obligated Group Financial Statements (Unaudited) (continued) 2. Fair Value Measurements (continued) Level 3: Pricing inputs are generally unobservable and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require management s judgment or estimation of assumptions that market participants would use in pricing the assets or liabilities. The fair values are therefore determined using factors that involve considerable judgment and interpretations, including not but limited to private and public comparables, third party appraisals, discounted cash flow models, and fund manager estimates. The obligated group does not hold any financial assets that would be included in this category. Assets and liabilities measured at fair value are based on one or more of three valuation techniques noted in FASB ASC 820 as identified below. The valuation techniques are as follows: (a) (b) (c) Market approach. Prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. This technique was utilized for all Level 1 and Level 2 investments except for the interest rate swaps. Cost approach. Amount that would be required to replace the service capacity of an asset (replacement cost). Income approach. Techniques to convert future amounts to a single present amount based on market expectations (including present value techniques, option-pricing and excess earnings model). This technique was utilized for interest rate swaps. The obligated group s investments in partnerships, limited liability companies, and similarly structured entities amounting to approximately $13.7 million and $13.5 million as of June 30, 2018 and June 30, 2017, respectively, are accounted for using the equity method of accounting, which is not a fair value measurement. 18

Notes to Obligated Group Financial Statements (Unaudited) (continued) 2. Fair Value Measurements (continued) The following table provides the composition of certain obligated group investment assets as of June 30, 2018. Only assets and liabilities measured at fair value on a recurring basis are shown in the three-tier fair value hierarchy. June 30, 2018 Quoted Prices In Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (In Thousands) Short-term investments: U.S. Treasury obligations $ 6,521 $ 6,521 $ - $ - Corporate bonds 22,174-22,174 - U.S. government agencies 4,087-4,087 - Commercial paper 3,586-3,586 - Negotiable certificates of deposit 4,280-4,280 - Asset-backed securities 140-140 - Supranational 3,809-3,809 - Interest receivable 243-243 - $ 44,840 $ 6,521 $ 38,319 $ - Long-term investments: U.S. Treasury obligations $ 57,783 $ 57,783 $ - $ - Corporate bonds 87,572-87,572 - U.S. government agencies 32,946-32,946 - Mortgaged-backed securities and collateralized mortgage obligations 4,126-4,126 - Asset-backed securities 19,716-19,716 - Supranational 12,665-12,665 - Interest receivable 1,171-1,171 - $ 215,979 $ 57,783 $ 158,196 $ - 19

Notes to Obligated Group Financial Statements (Unaudited) (continued) 2. Fair Value Measurements (continued) June 30, 2018 Quoted Prices In Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) (In Thousands) Significant Unobservable Inputs (Level 3) Assets limited as to use: Designated for property: Cash and cash equivalents $ 17,466 $ 17,466 $ - $ - Equities 1,275,838 1,275,838 - - U.S. Treasury obligations 355,460 355,460 - - Corporate bonds 331,863-331,863 - U.S. government agencies 61,656-61,656 - Mortgaged-backed securities and collateralized mortgage obligations 39,707-39,707 - Commercial paper 25,315-25,315 - Asset-backed securities 39,365-39,365 - Supranational 16,919-16,919 - Interest receivable 5,319-5,319 - $ 2,168,908 $ 1,648,764 $ 520,144 $ - Under bond indentures: Cash and cash equivalents $ 680 $ 680 $ - $ - U.S. Treasury obligations 45,632 45,632 - - Corporate bonds 53,031-53,031 - U.S. government agencies 2,805-2,805 - Commercial paper 8,963-8,963 - Asset-backed securities 7,918-7,918 - Supranational 14,090-14,090 - Interest receivable 486-486 - $ 133,605 $ 46,312 $ 87,293 $ - Interest rate swap receivable $ 6,251 $ - $ 6,251 $ - $ 6,251 $ - $ 6,251 $ - 20

Notes to Obligated Group Financial Statements (Unaudited) (continued) 2. Fair Value Measurements (continued) The following table provides the composition of certain obligated group investment assets as of June 30, 2017. Only assets and liabilities measured at fair value on a recurring basis are shown in the three-tier fair value hierarchy. June 30, 2017 Quoted Prices In Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) (In Thousands) Short-term investments: U.S. Treasury obligations $ 7,792 $ 7,792 $ - $ - Corporate bonds 33,044-33,044 - U.S. government agencies 5,056-5,056 - Commercial paper 6,267-6,267 - Asset-backed securities 110-110 - Bank certificates of deposit 75,000-75,000 - Interest receivable 210-210 - $ 127,479 $ 7,792 $ 119,687 $ - Long-term investments: U.S. Treasury obligations $ 58,649 $ 58,649 $ - $ - Corporate bonds 67,519-67,519 - U.S. government agencies 42,804-42,804 - Asset-backed securities 20,470-20,470 - Supranational 12,751-12,751 - Interest receivable 955-955 - $ 203,148 $ 58,649 $ 144,499 $ - 21

Notes to Obligated Group Financial Statements (Unaudited) (continued) 2. Fair Value Measurements (continued) June 30, 2017 Quoted Prices In Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) (In Thousands) Significant Unobservable Inputs (Level 3) Assets limited as to use: Designated for property: Cash and cash equivalents $ 2,398$ 2,398 $ - $ - Equities 1,080,756 1,080,756 - - U.S. Treasury obligations 290,024 290,024 - - Corporate bonds 316,722-316,722 - U.S. government agencies 102,372-102,372 - Mortgaged-backed securities and collateralized mortgage obligations 41,339-41,339 - Commercial paper 15,921-15,921 - Asset-backed securities 53,857-53,857 - Supranational 12,687-12,687 - Interest receivable 4,919-4,919 - $ 1,920,995$ 1,373,178 $ 547,817 $ - Under bond indentures: Cash and cash equivalents $ 1,740$ 1,740 $ - $ - U.S. Treasury obligations 9,466 9,466 - - Corporate bonds 17,785-17,785 - U.S. government agencies 11,871-11,871 - Commercial paper 3,726-3,726 - Asset-backed securities 3,796-3,796 - Supranational 2,400-2,400 - Interest receivable 203-203 - $ 50,987$ 11,206 $ 39,781 $ - Interest rate swap receivable $ 3,781$ - $ 3,781 $ - $ 3,781$ - $ 3,781 $ - 22

Notes to Obligated Group Financial Statements (Unaudited) (continued) 3. Investment Income Investment income for assets limited as to use, long-term investments, short-term investments and cash equivalents are comprised of the following: Nine Months Ended June 30, 2018 2017 (In Thousands) Interest income $ 42,259 $ 36,123 Unrealized gains (losses), net 16,178 (98,482) Realized gains, net 4,131 179,567 Investment income $ 62,568 $ 117,208 4. Endowments Sharp s endowments consist of 55 separate endowment funds included in assets limited as to use established for a variety of purposes. Its endowment includes both donor-restricted endowment funds and funds designated by the Board of Directors of Sharp s affiliated foundations to function as endowments. As required by GAAP, net assets associated with endowment funds, including funds designated by the Board of Directors to function as endowments, are classified and reported based on the existence or absence of donor-imposed restrictions. On September 30, 2008, California Senate Bill No. 1329 was signed into law which enacted the Uniform Prudent Management of Institutional Funds Act (UPMIFA) for California. California also adopted one of the optional provisions of the act, creating a rebuttable presumption of imprudence for spending more than 7% of the value of an endowment fund in one year (based on a three-year rolling average). The Board has interpreted UPMIFA as requiring the preservation of the fair value of the original gift as of the gift date of the donor-restricted endowment funds absent explicit donor stipulations to the contrary. As a result of this interpretation, Sharp classifies as permanently restricted net assets (a) the original value of gifts donated to the permanent endowment, (b) the original value of subsequent gifts to the permanent endowment, and (c) accumulations to the permanent endowment made in accordance with the direction of the applicable donor gift instrument at the time the accumulation is added to the fund. The remaining portion of the donor-restricted endowment fund that is not classified in permanently restricted net assets is classified as temporarily restricted net assets until those amounts are appropriated for expenditure by Sharp in a manner consistent with the standard of prudence prescribed by UPMIFA. In accordance with UPMIFA, Sharp considers the following factors in making a determination to appropriate or accumulate donor-restricted endowment funds: (1) the duration and preservation of the fund, (2) the purposes of Sharp and the donor-restricted endowment fund, (3) general economic conditions, (4) the possible effect of inflation and deflation, 23